Cover Image
市場調查報告書

Faron Pharmaceuticals Oy - 產品平台分析

Faron Pharmaceuticals Oy - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251665
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Faron Pharmaceuticals Oy - 產品平台分析 Faron Pharmaceuticals Oy - Product Pipeline Review - 2015
出版日期: 2015年05月27日 內容資訊: 英文 25 Pages
簡介

Faron Pharmaceuticals, Ltd. 是致力於研發血管障礙和發炎性疾病,癌症的轉移相關的急性外傷、代謝症侯群治療藥的製藥公司。

本報告提供Faron Pharmaceuticals Oy的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Faron Pharmaceuticals Oy的基本資料

Faron Pharmaceuticals Oy概要

  • 主要資訊
  • 企業資料

Faron Pharmaceuticals Oy:R&D概要

  • 主要的治療範圍

Faron Pharmaceuticals Oy:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Faron Pharmaceuticals Oy:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式

Faron Pharmaceuticals Oy

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Faron Pharmaceuticals Oy:藥物簡介

  • interferon beta-1a
  • FP-1304
  • FP-1101/1115

Faron Pharmaceuticals Oy:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Faron Pharmaceuticals Oy:最近的開發平台趨勢

Faron Pharmaceuticals Oy:暫停中的計劃

Faron Pharmaceuticals Oy:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07146CDB

Summary

Global Markets Direct's, 'Faron Pharmaceuticals Oy - Product Pipeline Review - 2015', provides an overview of the Faron Pharmaceuticals Oy's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Faron Pharmaceuticals Oy's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Faron Pharmaceuticals Oy including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Faron Pharmaceuticals Oy's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Faron Pharmaceuticals Oy's pipeline products

Reasons to buy

  • Evaluate Faron Pharmaceuticals Oy's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Faron Pharmaceuticals Oy in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Faron Pharmaceuticals Oy's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Faron Pharmaceuticals Oy and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Faron Pharmaceuticals Oy
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Faron Pharmaceuticals Oy and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Faron Pharmaceuticals Oy Snapshot
    • Faron Pharmaceuticals Oy Overview
    • Key Information
    • Key Facts
  • Faron Pharmaceuticals Oy - Research and Development Overview
    • Key Therapeutic Areas
  • Faron Pharmaceuticals Oy - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Faron Pharmaceuticals Oy - Pipeline Products Glance
    • Faron Pharmaceuticals Oy - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Faron Pharmaceuticals Oy - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Faron Pharmaceuticals Oy - Drug Profiles
    • interferon beta-1a
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-1304
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-1101/1115
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Faron Pharmaceuticals Oy - Pipeline Analysis
    • Faron Pharmaceuticals Oy - Pipeline Products by Target
    • Faron Pharmaceuticals Oy - Pipeline Products by Route of Administration
    • Faron Pharmaceuticals Oy - Pipeline Products by Molecule Type
    • Faron Pharmaceuticals Oy - Pipeline Products by Mechanism of Action
  • Faron Pharmaceuticals Oy - Recent Pipeline Updates
  • Faron Pharmaceuticals Oy - Dormant Projects
  • Faron Pharmaceuticals Oy - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Faron Pharmaceuticals Oy, Key Information
  • Faron Pharmaceuticals Oy, Key Facts
  • Faron Pharmaceuticals Oy - Pipeline by Indication, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Stage of Development, 2015
  • Faron Pharmaceuticals Oy - Monotherapy Products in Pipeline, 2015
  • Faron Pharmaceuticals Oy - Phase II, 2015
  • Faron Pharmaceuticals Oy - Preclinical, 2015
  • Faron Pharmaceuticals Oy - Discovery, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Target, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Route of Administration, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Molecule Type, 2015
  • Faron Pharmaceuticals Oy - Pipeline Products by Mechanism of Action, 2015
  • Faron Pharmaceuticals Oy - Recent Pipeline Updates, 2015
  • Faron Pharmaceuticals Oy - Dormant Developmental Projects,2015

List of Figures

  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Indication, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Stage of Development, 2015
  • Faron Pharmaceuticals Oy - Monotherapy Products in Pipeline, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Target, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Route of Administration, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Molecule Type, 2015
  • Faron Pharmaceuticals Oy - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top